Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $41,903 | 16 | 88.5% |
| Honoraria | $2,464 | 1 | 5.2% |
| Unspecified | $1,500 | 1 | 3.2% |
| Travel and Lodging | $793.31 | 3 | 1.7% |
| Food and Beverage | $613.14 | 8 | 1.3% |
| Education | $58.50 | 1 | 0.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $15,297 | 15 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $8,640 | 3 | $0 (2021) |
| Astellas Pharma Global Development | $8,250 | 3 | $0 (2021) |
| Amgen Inc. | $5,688 | 2 | $0 (2021) |
| Blueprint Medicines Corporation | $2,523 | 2 | $0 (2022) |
| Eli Lilly and Company | $2,400 | 1 | $0 (2021) |
| AbbVie Inc. | $1,575 | 1 | $0 (2021) |
| Celgene Corporation | $1,500 | 1 | $0 (2017) |
| Roche Diagnostics International Ltd | $1,400 | 1 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $59.26 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $123.12 | 1 | JAZZ PHARMACEUTICALS INC. ($123.12) |
| 2023 | $1,200 | 1 | JAZZ PHARMACEUTICALS INC. ($1,200) |
| 2022 | $12,076 | 13 | JAZZ PHARMACEUTICALS INC. ($9,494) |
| 2021 | $17,713 | 8 | Astellas Pharma Global Development ($8,250) |
| 2020 | $5,800 | 2 | Amgen Inc. ($4,400) |
| 2019 | $129.90 | 1 | JAZZ PHARMACEUTICALS INC. ($129.90) |
| 2018 | $5,190 | 2 | Jazz Pharmaceuticals Inc. ($3,750) |
| 2017 | $5,100 | 2 | Novartis Pharmaceuticals Corporation ($3,600) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/07/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug), VYXEOS, Defitelio | Food and Beverage | In-kind items and services | $123.12 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 02/17/2023 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/21/2022 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Consulting Fee | Cash or cash equivalent | $7,800.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/21/2022 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Travel and Lodging | Cash or cash equivalent | $126.57 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/30/2022 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Food and Beverage | In-kind items and services | $75.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/30/2022 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/30/2022 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/30/2022 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/29/2022 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Travel and Lodging | Cash or cash equivalent | $421.21 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/29/2022 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Travel and Lodging | Cash or cash equivalent | $245.53 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/29/2022 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Food and Beverage | In-kind items and services | $125.86 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/20/2022 | Blueprint Medicines Corporation | — | Honoraria | Cash or cash equivalent | $2,464.00 | General |
| 09/26/2022 | Blueprint Medicines Corporation | — | Education | In-kind items and services | $58.50 | General |
| 01/17/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $59.26 | General |
| 01/13/2022 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/17/2021 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/11/2021 | Amgen Inc. | Blincyto (Biological) | Consulting Fee | Cash or cash equivalent | $1,288.00 | General |
| Category: Oncology | ||||||
| 06/25/2021 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| 04/28/2021 | Astellas Pharma Global Development | XOSPATA (Drug) | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| Category: ONCOLOGY | ||||||
| 03/31/2021 | Astellas Pharma Global Development | XOSPATA (Drug) | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| Category: ONCOLOGY | ||||||
| 03/19/2021 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $3,600.00 | General |
| 02/18/2021 | AbbVie Inc. | — | Consulting Fee | Cash or cash equivalent | $1,575.00 | General |
| 02/12/2021 | Astellas Pharma Global Development | XOSPATA (Drug) | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2020 | Roche Diagnostics International Ltd | RDI Research (Device) | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: Point of Care | ||||||
| 09/04/2020 | Amgen Inc. | Blincyto (Biological) | Consulting Fee | Cash or cash equivalent | $4,400.00 | General |
| Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| CC-5013-AML-001 | Celgene Corporation | $1,500 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 235 | 369 | $96,469 | $9,625 |
| 2022 | 8 | 280 | 404 | $99,166 | $10,567 |
| 2021 | 9 | 356 | 525 | $127,037 | $13,954 |
| 2020 | 8 | 308 | 481 | $114,109 | $13,312 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 46 | 95 | $26,604 | $2,819 | 10.6% |
| 85097 | Bone marrow, smear interpretation | Facility | 2023 | 45 | 53 | $19,366 | $2,118 | 10.9% |
| 88189 | Flow cytometry technique for dna or cell analysis, 16 or more markers | Facility | 2023 | 24 | 27 | $22,050 | $1,889 | 8.6% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2023 | 46 | 108 | $9,561 | $1,058 | 11.1% |
| 88188 | Flow cytometry technique for dna or cell analysis, 9 to 15 markers | Facility | 2023 | 14 | 14 | $9,372 | $725.48 | 7.7% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2023 | 45 | 56 | $5,292 | $564.94 | 10.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 15 | 16 | $4,224 | $450.72 | 10.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 53 | 97 | $26,222 | $2,973 | 11.3% |
| 85097 | Bone marrow, smear interpretation | Facility | 2022 | 52 | 54 | $19,048 | $2,197 | 11.5% |
| 88188 | Flow cytometry technique for dna or cell analysis, 9 to 15 markers | Facility | 2022 | 22 | 24 | $15,492 | $1,289 | 8.3% |
| 88189 | Flow cytometry technique for dna or cell analysis, 16 or more markers | Facility | 2022 | 18 | 18 | $14,136 | $1,288 | 9.1% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2022 | 53 | 110 | $9,396 | $1,122 | 11.9% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2022 | 53 | 55 | $4,999 | $576.77 | 11.5% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 11 | 27 | $5,043 | $576.06 | 11.4% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 18 | 19 | $4,830 | $545.48 | 11.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2021 | 67 | 119 | $30,895 | $3,642 | 11.8% |
| 85097 | Bone marrow, smear interpretation | Facility | 2021 | 60 | 66 | $22,394 | $2,660 | 11.9% |
| 88189 | Flow cytometry technique for dna or cell analysis, 16 or more markers | Facility | 2021 | 25 | 29 | $21,995 | $2,108 | 9.6% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2021 | 63 | 142 | $11,715 | $1,399 | 11.9% |
| 88188 | Flow cytometry technique for dna or cell analysis, 9 to 15 markers | Facility | 2021 | 24 | 24 | $14,928 | $1,244 | 8.3% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2021 | 26 | 29 | $7,100 | $854.05 | 12.0% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2021 | 63 | 69 | $6,036 | $707.15 | 11.7% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2021 | 11 | 28 | $5,054 | $671.16 | 13.3% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2021 | 17 | 19 | $6,920 | $669.36 | 9.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2020 | 61 | 119 | $29,835 | $3,802 | 12.7% |
About Daniel Arber
Daniel Arber is a Anatomic Pathology & Clinical Pathology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174614267.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Arber has received a total of $47,332 in payments from pharmaceutical and medical device companies, with $123.12 received in 2024. These payments were reported across 30 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($41,903).
As a Medicare-enrolled provider, Arber has provided services to 1,179 Medicare beneficiaries, totaling 1,779 services with total Medicare billing of $47,458. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Location Chicago, IL
- Active Since 09/27/2006
- Last Updated 10/24/2022
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- NPI Number 1174614267
Products in Payments
- VYXEOS (Drug) $15,174
- XOSPATA (Drug) $8,250
- Blincyto (Biological) $5,688
- RYDAPT (Drug) $5,040
- Revlimid (Drug) $1,500
- RDI Research (Device) $1,400
- RYLAZE (Drug) $123.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology & Clinical Pathology Doctors in Chicago
Jeffrey Mueller
Anatomic Pathology & Clinical Pathology — Payments: $145,201
Lindsay Alpert
Anatomic Pathology & Clinical Pathology — Payments: $27,799
Dr. Brett Mahon, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $18,770
Namrata Setia
Anatomic Pathology & Clinical Pathology — Payments: $15,166
Carlos Garcia, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $8,026
Melissa Tjota, Md, Phd, MD, PHD
Anatomic Pathology & Clinical Pathology — Payments: $5,360